bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 188.30% | 147.15% | 497.77% | 1,149.79% | 961.15% |
| Total Other Revenue | -97.22% | -37.50% | 12.50% | -11.79% | -49.71% |
| Total Revenue | 184.12% | 144.50% | 483.73% | 1,032.60% | 719.82% |
| Cost of Revenue | 166.59% | 145.41% | 158.79% | 140.08% | 125.47% |
| Gross Profit | -38.29% | -113.14% | -115.28% | -105.91% | -102.98% |
| SG&A Expenses | -0.22% | 1.68% | 10.19% | 6.27% | 2.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 100.00% | 100.00% | 100.00% | 8.89% |
| Total Operating Expenses | 28.40% | 219.34% | 328.79% | 221.00% | 10.01% |
| Operating Income | -9.60% | -236.53% | -311.67% | -192.32% | 0.40% |
| Income Before Tax | -13.49% | -367.96% | -515.48% | -237.41% | 7.90% |
| Income Tax Expenses | 155.56% | -376.67% | -167.57% | -207.69% | -207.69% |
| Earnings from Continuing Operations | -13.59% | -367.60% | -515.00% | -236.82% | 8.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.59% | -367.60% | -515.00% | -236.82% | 8.00% |
| EBIT | -9.60% | -236.53% | -311.67% | -192.32% | 0.40% |
| EBITDA | 4.30% | -272.67% | -351.75% | -193.96% | 8.93% |
| EPS Basic | 33.72% | -356.18% | -328.30% | -85.04% | 40.46% |
| Normalized Basic EPS | 34.54% | -353.26% | -312.59% | -95.68% | 39.06% |
| EPS Diluted | 33.96% | -346.55% | -320.75% | -83.87% | 40.36% |
| Normalized Diluted EPS | 34.57% | -352.47% | -312.08% | -95.57% | 39.04% |
| Average Basic Shares Outstanding | 76.48% | 72.28% | 62.42% | 54.17% | 39.80% |
| Average Diluted Shares Outstanding | 76.33% | 72.12% | 62.25% | 54.00% | 39.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
